Table 1B.
HN | MOTS-c | ADP | ||
---|---|---|---|---|
p | p | p | ||
Control | Pre-diabetes | <0.0001 | 0.07 | 0.098 |
Well-controlled T2D | <0.0001 | 0.777 | 0.184 | |
Poorly-controlled T2D | <0.0001 | 0.008 | 0.001 | |
Pre-diabetes | Control | <0.0001 | 0.07 | 0.098 |
Well-controlled T2D | 0.22 | 1 | 1.000 | |
Poorly-controlled T2D | <0.0001 | 1 | 1.000 | |
Well-controlled T2D | Control | <0.0001 | 0.777 | 0.184 |
Pre-diabetes | 0.22 | 1 | 1.000 | |
Poorly-controlled T2D | 0.157 | 1 | 1.000 | |
Poorly-controlled T2D | Control | <0.0001 | 0.008 | 0.001 |
Pre-diabetes | <0.0001 | 1 | 1.000 | |
Well-controlled T2D | 0.157 | 1 | 1.000 |
Table shows post-hoc analysis comparing HN, MOTS-c, and ADP between control, prediabetes, well-controlled T2D and in poorly-controlled T2D subjects.